Latest News

• June 2005
• Scancell Raises £1.0 Million In Rights Issue
• January 2005
• Scancell Signs New Agreement with Biovation to DeImmunise SC101
• May 2004
• Scancell Secures Exclusive Worldwide Licence Agreement
• April 2004
• Scancell Raises £1.3 Million ($2.34M; €2M) in New Funding Round
• Scancell Appoints Dr Michael Capaldi as CEO
• December 2003
• Scancell, Onyvax and CRT Announce Agreement to Facilitate the Development of "ImmunoBody"
• August 2003
• Scancell and Celltech Announce that they will Collaborate on the Development of Novel Monoclonal
• February 2002
• Scancell and Isu Chemical Announce Collaboration and Licensing Agreement for Scancell's Antibody
• October 2001
• Genmab and Scancell Announce Cancer Antibody Product Collaboration — First Disease Target Identified